Abstract
The development of antiviral drugs for Ebola and Marburg viruses has been slow. To date, beyond supportive care, no effective treatments, prophylactic measures, therapies, or vaccines are approved to treat or prevent filovirus infections. In this review, we examine the current treatments available to administer care for filovirus infection, the potential therapeutic targets that can be used for filovirus drug development, and the various drug targeting techniques used against filoviruses.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 191-200 |
| Number of pages | 10 |
| Journal | Infectious Disorders - Drug Targets |
| Volume | 9 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 1 2009 |
| Externally published | Yes |
Keywords
- Drug targets
- Ebola virus
- Filoviridae
- Immunotherapy
- Marburg virus
- Pathogenesis
- Pathology
- Therapeutics
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology
- Microbiology (medical)
Fingerprint Dive into the research topics of 'Drug targets in infections with Ebola and Marburg viruses'. Together they form a unique fingerprint.
Cite this
Gene, O. G., Julia, B. E., Vanessa, M. R., Victoria, W. J., Thomas, G. W., & Lisa, H. E. (2009). Drug targets in infections with Ebola and Marburg viruses. Infectious Disorders - Drug Targets, 9(2), 191-200. https://doi.org/10.2174/187152609787847730